US 8,208,065

Application 12/413,146 · Granted Jun 26, 2012

Method, apparatus, and computer software for digital video scan rate conversions with minimization of artifacts

Estimated expiration

December 8, 2030

4y 17d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
Earliest effective filing
Mar 27, 2009
+ 20 years
Mar 27, 2029
PTA +621d
Dec 8, 2030
No TD
—
Final
Dec 8, 2030

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation details

Base term

Filing date
March 27, 2009
Earliest effective filing
March 27, 2009
Issue date
June 26, 2012
PTA
+621 days
Base expiry (before PTA)
March 27, 2029

March 27, 2009 + 20 years = March 27, 2029 + 621 PTA days = December 8, 2030

  • PRO61/141,304 — Provisional — not used for base term
  • PRO61/084,828 — Provisional — not used for base term

Terminal disclaimers

No TD0 approved, 0 filed

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 12/413,146 · US 8,208,065

PatentReply compiles the prosecution history behind US 8,208,065: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US8208065

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.